Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Crown Holdings
CCK
$13B
| $1.06M | 0.03% |
+11,534
| New | +$1.23M |
|
|
TMHC
852
DELISTED
Taylor Morrison
TMHC
| $1.06M | 0.03% |
+45,481
| New | +$1.2M |
|
|
JMAC
853
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
| $1.06M | 0.03% |
105,000
| – | – |
|
854
CALL
Walmart Inc
WMT
$847B
| $1.06M | 0.03% |
26,100
+9,300
| +55% | +$429K |
|
855
Century Aluminum
CENX
$4.32B
| $1.05M | 0.03% |
142,945
+65,946
| +86% | +$1.02M |
|
|
CVET
856
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.05M | 0.03% |
50,737
-121,042
| -70% | -$2.15M |
|
857
CALL
CSX Corp
CSX
$95.3B
| $1.05M | 0.03% |
36,200
+24,200
| +202% | +$789K |
|
858
CALL
Advanced Micro Devices
AMD
$746B
| $1.05M | 0.03% |
13,700
+7,300
| +114% | +$683K |
|
859
CALL
LyondellBasell Industries
LYB
$21.1B
| $1.05M | 0.03% |
12,000
+8,700
| +264% | +$906K |
|
860
Dine Brands
DIN
$457M
| $1.05M | 0.03% |
16,080
+7,563
| +89% | +$540K |
|
|
TGNA
861
DELISTED
TEGNA Inc
TGNA
| $1.05M | 0.03% |
49,868
-625,000
| -93% | -$13.5M |
|
862
Enovis
ENOV
$1.45B
| $1.04M | 0.03% |
+18,982
| New | +$1.22M |
|
863
CALL
HCA Healthcare
HCA
$92.9B
| $1.04M | 0.03% |
6,200
+5,300
| +589% | +$1.14M |
|
864
iRhythm Holdings
IRTC
$4.13B
| $1.04M | 0.03% |
+9,632
| New | +$1.28M |
|
865
Assurant
AIZ
$14.2B
| $1.04M | 0.03% |
+6,016
| New | +$1.09M |
|
866
Bruker
BRKR
$8.68B
| $1.04M | 0.03% |
16,547
-2,575
| -13% | -$158K |
|
867
Carlyle Group
CG
$17.5B
| $1.04M | 0.03% |
+32,717
| New | +$1.25M |
|
868
Murphy Oil
MUR
$5.16B
| $1.04M | 0.03% |
+34,331
| New | +$1.32M |
|
869
PUT
Amazon
AMZN
$2.83T
| $1.03M | 0.03% |
+9,700
| New | +$1.21M |
|
870
CALL
Bank of America
BAC
$436B
| $1.03M | 0.03% |
+33,300
| New | +$1.2M |
|
871
Korn Ferry
KFY
$4.35B
| $1.02M | 0.03% |
17,651
+5,123
| +41% | +$311K |
|
|
RVNC
872
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.02M | 0.03% |
74,119
-15,453
| -17% | -$238K |
|
873
SolarEdge
SEDG
$1.85B
| $1.02M | 0.03% |
3,727
-5,350
| -59% | -$1.46M |
|
874
Newmark Group
NMRK
$2.91B
| $1.02M | 0.03% |
105,127
+36,559
| +53% | +$423K |
|
875
Hershey
HSY
$38.2B
| $1.01M | 0.03% |
+4,717
| New | +$1.03M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.